Learn More
Medchemexpress LLC Lqz-7i | 195822-23-2 | 99.8% | C20H14F2N4 | 10MG

Supplier: Medchemexpress LLC HY13653810MG
LQZ-7I is a small-molecule survivin-targeting inhibitor that disrupts survivin dimerization, induces proteasome-mediated survivin degradation, and has demonstrated oral antitumor activity in xenograft models. It is supplied as a high-purity solid with documented solubility and storage conditions for use in cellular and in vivo oncology research.
- Inhibits survivin dimerization and promotes survivin degradation.
- Demonstrates oral efficacy in xenograft tumor models.
- High reported purity suitable for research applications.
- Soluble in DMSO; in vivo formulation protocols available.
- Available in multiple small pack sizes for preclinical studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.